Biochemical Engineering
Oxford vaccines spinout Vaccitech raises $168M
17th March 2021
The Series B round of funding for University of Oxford spinout Vaccitech includes the type of financial backers that could support an IPO. While Vaccitech might be best known for its association with AstraZeneca's Covid-19 vaccine, the startup also has programs for other infectious diseases and cancer. Source: MedCity News 17/3/21
Back to group news